SCHEMBL7841796

SCHEMBL7841796

CCc1nc(-c2ccc(F)cc2)c(-c2cc(C)cs2)s1

nearest known ligand 0.54

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 8/20 0.54
PTGS1 P23219 1/20 0.54
MAPK14 Q16539 12/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7843106 0.85 PTGS2 (0.57) PTGS2PTGS1MAPK14
SCHEMBL7839802 0.85 PTGS2 (0.57) PTGS2PTGS1MAPK14
SCHEMBL7847056 0.84 PTGDR2 (0.48) PTGS2PTGS1MAPK14
SCHEMBL7833920 0.84 PTGS2 (0.58) PTGS2PTGS1MAPK14
SCHEMBL7844988 0.84 PTGS2 (0.52) PTGS2PTGS1MAPK14
SCHEMBL7844371 0.83 PTGS2 (0.60) PTGS2PTGS1MAPK14
SCHEMBL7842827 0.81 PPARD (0.49) PTGS2PTGS1
SCHEMBL7852859 0.80 PTGS1 (0.51) PTGS2PTGS1
SCHEMBL7845639 0.80 PTGS1 (0.61) PTGS2PTGS1
SCHEMBL7844733 0.80 PTGS2 (0.54) PTGS2PTGS1MAPK14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1125932-A2 Substituted thiazoles for the treatment of inflammation G.D. SEARLE & CO. (US) 2001-08-22 EP disclosed
US-5668161-A Substituted thiazoles for the treatment of inflammation G.D. SEARLE & CO. (US) 1997-09-16 US disclosed
EP-0772606-A1 SUBSTITUTED THIAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1997-05-14 EP disclosed
WO-1996003392-A1 SUBSTITUTED THIAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-02-08 WO disclosed